EMA Application withdrawn: DuoCover (clopidogrel;acetylsalicylic acid) — Bristol Myers Squibb Pharma EEIG

View source ↗

Summary

EMA withdrew the application for DuoCover (clopidogrel and acetylsalicylic acid) from Bristol Myers Squibb Pharma EEIG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Vascular Diseases
• Vascular Surgical Procedures

Drugs mentioned

• DuoCover

Snippet

Status: Application withdrawn. Therapeutic area: Vascular Surgical Procedures;Peripheral Vascular Diseases;Myocardial Infarction;Acute Coronary Syndrome. MAH: Bristol Myers Squibb Pharma EEIG. Decision date: 31/12/2009